Article ID Journal Published Year Pages File Type
2973165 The Journal of Heart and Lung Transplantation 2006 6 Pages PDF
Abstract
The choice of immunosuppressive regimen may affect the likelihood of developing malignancy after OHT. Induction immunosuppression does not appear to increase the risk of subsequent malignancy. The use of MMF in standard immunosuppressive regimens is associated with a significantly lower risk of developing malignancy.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Mycophenolate Mofetil and Risk of Developing Malignancy After Orthotopic Heart Transplantation: Analysis of the Transplant Registry of the International Society for Heart and Lung Transplantation
Authors
, , , ,